National and Kapodistrian University of Athens
Αναζήτηση ερπητοϊών σε χρόνιες φλεγμονώδεις νόσους του εντέρου (ΙΦΝΕ)
Abstract
dc:descriptionBackground: Although a growing number of reports have described inflammatory bowel disease (IBD) complicated with cytomegalovirus (CMV) and Ebstein Barr (EBV) infection, there are limited molecular studies that investigate CMV and EBV genome in intestinal sections of patients with IBD. Methods: A cross-sectional prospective study was conducted between September 2000 and June 2003 in a cohort of 85 patients diagnosed with IBD (58 with ulcerative colitis and 27 with Crohn’s disease) in 2 adult gastrointestinal referral centers in Athens, Greece. Prevalence of CMV and EBV infection was estimated by pathologic studies in intestinal sections and by molecular assays in blood and intestinal tissue samples of IBD patients and compared with those from a control group of 45 individuals with noninflammatory diseases. Results: Immunohistochemical staining showed CMV antigen in 18 IBD patients (13 with ulcerative colitis, 16 with severe disease), whereas CMV antigen was not detected in any of the controls. CMV genome in both the intestinal tissue [29 (34,1%) of the 85 patients] and blood [23 (28%) of the 82 patients] was found by polymerase chain reaction. 21 (36,2%) out of 29 CMV positive patients had ulcerative colitis and the remaining 8 (29,6%) had Crohn’s disease. In addition, five (5,9%) IBD patients (2 with ulcerative colitis and 3 with Crohn’s disease) had detectable CMV genome in their intestinal samples but not in their blood. In the control group, five (11,6%) individuals had detectable CMV genome in their blood, but only one (2,6%) in his intestine. EBV detection in the intestinal tissue by PCR revealed 43/75 (57%) positive patients; 31/53 (58%) had ulcerative colitis and 12/22 (54%) had Crohn’s disease. EBV detection in blood by PCR revealed 24/88 (27%) positive patients. In addition 26 (68%) patients with clinically severe ulcerative colitis more often had detectable EBV genome in their intestinal tissue as well as the 11(73%) patients with severe Crohn’s disease. In the control group, 20 (44%) individuals had detectable EBV genome in their blood but only 6 (15%) in their intestine. Conclusion: Patients with ulcerative colitis had more often detectable CMV genome in their blood as well as in their intestinal tissue samples compared with controls (p= 0.036 and p<0,0001, respectively). However, patients with Crohn’s disease had more often detectable CMV genome only in their intestinal tissue samples compared with controls (p=0,0005). Detection of CMV genome in blood or intestinal tissue was significantly associated with short duration of IBD (p=0,0088 and 0,04, respectively) but not with age, sex, severity of the disease, activity at colonoscopy, pancolitis, administration of a specific treatment, and surgery. In this cross-sectional prospective study, detection of CMV genome or antigen in the intestine was commonly associated with IBD. Patients with ulcerative colitis compared with control subjects more often had detectable EBV genome only in their intestinal tissue (p=0,00001). The same was noticed with Crohn’s disease not only in the intestinal tissue but also in the blood (p=0,0013 and p=0,016 respectively). In addition patients with clinically severe IBD (ulcerative colitis and Crohn disease) more often had detectable EBV genome in their intestinal tissue (p=0,0195 and p=0,096 respectively).
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dimitroulia, E.
- Δημητρούλια, Ευαγγελία
Subjects
dc:subject × 23- Ελκώδης κολίτιδα
- Χρόνιες φλεγμονώδεις νόσοι εντέρου
- Ιοί
- Κυτταρομεγαλοϊός
- Έντερα
- Νόσοι
- Αλυσιδωτή αντίδραση πολυμεράσης
- Αίμα
- Εντερικός ιστός
- Ulcerative colitis
- CMV
- EBV
- Inflammatory Bowel Diseases (IBD)
- Viruses
- Bowel
- Epstein-Barr virus (EBV)
- Diseases
- Polymerase chain reaction (PCR)
- Blood
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18566